Literature DB >> 6524111

[Biomechanical studies on the pathogenesis of ochronotic arthropathy].

P Eberle, W Mohr, L Claes.   

Abstract

The enzymatic defect leading to alcaptonuria is well known. However, the pathogenesis of the associated arthropathy is poorly understood. From clinical and morphological observations it is assumed that the breakdown of ochronotic cartilage is due to an increased fragility. To test the hypothesis that polymerisation products of homogentisic acid change the biomechanical behaviour of hyalin cartilage, investigations on natural ochronotic cartilage and tissues following in vitro incubation with homogentisic acid were performed. It could be demonstrated that the "ochronotic situation" is associated with an increased hardness and a decreased elasticity of the hyalin cartilage. For the pathogenesis of ochronotic arthropathy it is assumed that these alterations, in association with mechanical stress to the joints, lead to cartilage destruction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524111

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  4 in total

1.  Ochronotic arthropathy, an approach to osteoarthritis bone remodelling.

Authors:  René Lagier
Journal:  Rheumatol Int       Date:  2006-04       Impact factor: 2.631

Review 2.  [Severe osteoarthritic manifestations of ochronosis].

Authors:  U Lange; U Müller-Ladner; G Dischereit
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

3.  [Acute bilateral shoulder pain as initial presentation of ochronosis: a case report and literature review].

Authors:  N Laktasic-Zerjavic; B Curkovic; D Babic-Naglic; K Potocki; M Prutki; D Soldo-Juresa
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

4.  Black hip, fracture neck of femur and scoliosis: a case of ochronosis.

Authors:  B Zacharia; J Chundarathil; V Ramakrishnan; R M Krishnankutty; R Veluthedath; K Puthezhath; I Varughese
Journal:  J Inherit Metab Dis       Date:  2009-06-07       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.